Loading clinical trials...
Loading clinical trials...
Investigation of the Role of Redox Status of Patients With Autoimmune Rheumatic Diseases on Disease Progression: An Epidemiological Study
Conditions
Locations
1
Greece
General University Hospital of Larissa. Greece
Larissa, Thessaly, Greece
Start Date
October 6, 2025
Primary Completion Date
April 30, 2026
Completion Date
October 1, 2026
Last Updated
April 17, 2026
NCT07048197
NCT07484243
NCT06647069
NCT07268326
NCT06599658
NCT04806620
Lead Sponsor
University of Thessaly
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions